"Biocon's continuous investment in infrastructure and technology is aligned with its R&D focus to develop and commercialize novel therapeutic products"
- Prasad B.S.V. Vice President, Operations
The breadth and scale of Biocon’s manufacturing technologies has dovetailed our transition from a niche player in specialty enzymes to a global provider of biopharmaceuticals spanning small molecules, recombinant proteins, peptides and monoclonal antibodies. These technologies encompass large-scale microbial fermentation, chemical synthesis, mammalian cell culture, protein & antibody purification, aseptic formulation and fill-finish. Our manufacturing facilities are designed to stringent cGMP standards and are supported by state-of-the-art process development and quality control laboratories and an efficient service infrastructure. We currently operate on two sites in Bangalore, both of which have successfully passed inspection by local and international regulatory agencies, including US FDA and EDQM.